Last updated on February 2018

Bologna IBD Markers

Brief description of study

Individuate possible predictive factors of anti-TNFalfa-induced deep remission in Crohn's disease.

Detailed Study Description

This trial will be exploratory, open in vitro study on human tissues. 120 patients will be enrolled (Caucasian, male/female,18-65 years old) with moderate-severe active Crohns disease and with indication for anti-TNF therapy according to the normal clinical practice.

Simultaneously, 30 no-IBD controls with no GI disorders, as defined by medical history and standard clinical chemistry values, afferent to the out-patient clinic will be enrolled.

Clinical Study Identifier: NCT02580864

Contact Investigators or Research Sites near you

Start Over


Bologna University
Bologna, Italy